Estrogen, Cytokines and Heart Failure in Women
NCT00041431 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2016-05-13
Summary
To determine the effects of estrogen therapy on postmenopausal women with congestive heart failure.
Conditions
- Cardiovascular Diseases
- Heart Failure, Congestive
- Heart Diseases
- Menopause
Interventions
- DRUG
-
Hormone Replacement Therapy
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Steven Reis · University of Pittsburgh
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
Eligibility
- Max Age
- 100 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-12-31
- Completion
- 2003-12-31
More Related Trials
-
Hormone Therapy Effects on CVD Risk Factors
NCT00006313 ·Status: COMPLETED
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Myocardial Infarction and Non-contraceptive Estrogen Use
NCT00005185 ·Status: COMPLETED
-
Estrogen Replacement and Atherosclerosis (ERA) in Older Women
NCT00000549 ·Status: COMPLETED ·Phase: PHASE3
-
Estrogen Diastolic Heart Failure
NCT02693002 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
NCT00005108 ·Status: COMPLETED ·Phase: PHASE2
-
Stroke and MI in Users of Estrogen/Progestogen
NCT00005466 ·Status: COMPLETED
-
Hormone Replacement Therapy and Prothrombotic Variants
NCT00049933 ·Status: COMPLETED
-
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
NCT04453332 ·Status: UNKNOWN ·Phase: NA
-
Menopause Effects on Vascular Function
NCT03236545 ·Status: COMPLETED ·Phase: NA
-
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
NCT00001752 ·Status: COMPLETED ·Phase: PHASE2
-
Midlife Cholesterol Study
NCT00361075 ·Status: COMPLETED ·Phase: PHASE4
-
Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
NCT01633814 ·Status: TERMINATED ·Phase: NA
-
Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
NCT00000559 ·Status: COMPLETED ·Phase: PHASE3
-
CVD Risk and Health in Postmenopausal Phytoestrogen Users
NCT00000613 ·Status: COMPLETED ·Phase: PHASE2
-
Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer
NCT00079248 ·Status: UNKNOWN ·Phase: NA
-
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
NCT00123539 ·Status: TERMINATED ·Phase: NA
-
Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death
NCT00580775 ·Status: COMPLETED
-
Estrogen Hormone Products
NCT05645406 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Hormonal Replacement Therapy and Small Artery Function
NCT00564031 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot Flashes
NCT00547001 ·Status: UNKNOWN ·Phase: NA
-
The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans
NCT07212712 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
NCT00001890 ·Status: COMPLETED ·Phase: PHASE2
-
Perimenopausal Estrogen Replacement Therapy Study
NCT01308814 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
NCT02042196 ·Status: COMPLETED ·Phase: EARLY_PHASE1